InfoSynergy
Timolol eye drops can produce systemic beta-blockade through nasolacrimal absorption, especially in older adults. Like systemic beta-blockers, timolol inhibits mitochondrial CoQ10-dependent enzymes; CoQ10 supplementation may help, though the systemic exposure with ophthalmic dosing is lower than with oral therapy.
Recommendation: If you use timolol eye drops and experience fatigue or systemic beta-blocker symptoms (bradycardia, exercise intolerance), consider CoQ10 100-200 mg/day. Punctal occlusion when administering drops also reduces systemic absorption.
InfoCaution
Systemic absorption of timolol eye drops can blunt nocturnal melatonin production by blocking beta1 receptors on the pineal gland, similar to oral beta-blockers. Supplemental melatonin can restore sleep quality in patients affected by this side effect.
Recommendation: If you have insomnia after starting timolol eye drops, try punctal occlusion (pressing on the inner corner of the eye after instillation) to reduce systemic absorption. Low-dose melatonin (0.3-3 mg at bedtime) can help restore sleep if symptoms persist.
ModerateCaution
Timolol eye drops can be systemically absorbed and produce beta-blocker effects such as slower heart rate, lower blood pressure, dizziness, or syncope. Alcohol can worsen orthostatic blood pressure control and psychomotor impairment. The combination is most important in older adults, people with low resting heart rate, conduction disease, falls, or other blood-pressure medicines.
Recommendation: Limit alcohol when starting timolol eye drops and avoid drinking if you have dizziness, fainting, or a very low pulse. Use punctal occlusion after each dose to reduce systemic absorption. Seek care for fainting, chest pain, wheezing, severe shortness of breath, or persistent heart rate below your clinician's threshold.
ModerateCaution
L-Arginine can modestly lower blood pressure through nitric-oxide-mediated vasodilation. Timolol eye drops can be systemically absorbed and lower heart rate or blood pressure in susceptible patients. Together they may increase lightheadedness, fatigue, or fainting risk, especially in older adults or people already on cardiovascular medications.
Recommendation: Start L-Arginine cautiously if you use timolol eye drops, and monitor blood pressure and pulse for 1-2 weeks. Use punctal occlusion after timolol dosing. Stop or reduce L-Arginine and contact your prescriber if you develop dizziness, fainting, unusual fatigue, wheezing, or a very slow pulse.
ModerateCaution
L-Citrulline increases arginine availability and can modestly lower blood pressure. Timolol eye drops can reach systemic circulation and produce beta-blocker effects such as bradycardia, hypotension, and dizziness. The combination may be noticeable in people with low baseline blood pressure, low pulse, fall risk, or multiple cardiovascular medicines.
Recommendation: If you add L-Citrulline while using timolol eye drops, start with a low dose and track blood pressure and pulse. Use punctal occlusion after each eye drop dose. Stop or reduce L-Citrulline and contact your prescriber if you develop fainting, persistent dizziness, unusual fatigue, wheezing, or slow pulse.